Literature DB >> 18484675

A pilot MRI study of organ specific hemosiderosis and functional correlation in Chinese patients with myelodysplasia and aplastic anemia with raised ferritin levels.

Wy Au1, Wwm Lam, Wwc Chu, S Tam, Wk Wong, H Chan, Mf Law, Hsy Liu, R Liang.   

Abstract

We performed MRI and endocrine assessment in 27 adult Chinese patients with severe aplastic anemia (SAA) and myelodysplasia (MDS). Despite high ferritin levels, cardiac hemosiderosis and heart failure was not common, and were not concordant in most cases. However, significant correlation was found between cardiac T2/T2* MRI assessment, ejection fraction and ferritin levels. Furthermore, there was a high incidence subclinical pancreatic abnormality that was related to liver MRI T2* readings. Hence, chelating agents may still have a role to improve organ function. Prospective data with serial functional and imaging monitoring is needed. Copyright (c) 2008 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484675     DOI: 10.1002/hon.862

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  5 in total

Review 1.  Iron chelation therapy in myelodysplastic syndromes: where do we stand?

Authors:  Mhairi Mitchell; Steven D Gore; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-08       Impact factor: 2.929

Review 2.  Liver iron content determination by magnetic resonance imaging.

Authors:  Konstantinos Tziomalos; Vassilios Perifanis
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

3.  Myocardial T2 quantitation in patients with iron overload at 3 Tesla.

Authors:  Hua Guo; Wing-Yan Au; Jerry S Cheung; Daniel Kim; Jens H Jensen; Pek-Lan Khong; Queenie Chan; Kevin C Chan; Christina Tosti; Haiying Tang; Truman R Brown; Wynnie W M Lam; Shau-Yin Ha; Gary M Brittenham; Ed X Wu
Journal:  J Magn Reson Imaging       Date:  2009-08       Impact factor: 4.813

4.  Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications.

Authors:  Sylvia Titi Singer; Hae-Young Kim; Nancy F Olivieri; Janet L Kwiatkowski; Thomas D Coates; Susan Carson; Ellis Neufeld; Melody J Cunningham; Patricia J Giardina; Brigitta U Mueller; Charles T Quinn; Ellen Fung; Elliott Vichinsky
Journal:  Am J Hematol       Date:  2009-11       Impact factor: 10.047

5.  Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.

Authors:  Norbert Gattermann; Andrea Jarisch; Rudolf Schlag; Klaus Blumenstengel; Mariele Goebeler; Matthias Groschek; Christoph Losem; Maria Procaccianti; Alexia Junkes; Oliver Leismann; Ulrich Germing
Journal:  Eur J Haematol       Date:  2011-11-24       Impact factor: 2.997

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.